{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:24:08Z","timestamp":1792027448832,"version":"4.4.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"DOI":"10.1186\/s13054-026-06109-3","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T13:25:33Z","timestamp":1781184333000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current and future strategies aiming at reducing catecholamine exposure in septic shock"],"prefix":"10.1186","volume":"30","author":[{"given":"Arthur","family":"Dubech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Picod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Preau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Favory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"6109_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"6109_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2478-6","volume":"23","author":"J-L Vincent","year":"2019","unstructured":"Vincent J-L, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23:196. https:\/\/doi.org\/10.1186\/s13054-019-2478-6.","journal-title":"Crit Care"},{"key":"6109_CR3","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/aln.0000000000004958","volume":"140","author":"E Antonucci","year":"2024","unstructured":"Antonucci E, Garcia B, Legrand M. Hemodynamic support in sepsis. Anesthesiology. 2024;140:1205\u201320. https:\/\/doi.org\/10.1097\/aln.0000000000004958.","journal-title":"Anesthesiology"},{"key":"6109_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000007075","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, M\u00f8ller MH, Alshamsi F, Azevedo LCP, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Crit Care Med. 2026. https:\/\/doi.org\/10.1097\/ccm.0000000000007075.","journal-title":"Crit Care Med"},{"key":"6109_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/nejmoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779\u201389. https:\/\/doi.org\/10.1056\/nejmoa0907118.","journal-title":"N Engl J Med"},{"key":"6109_CR6","first-page":"165","volume":"38","author":"CR Benedict","year":"1992","unstructured":"Benedict CR, Rose JA. Arterial norepinephrine changes in patients with septic shock. Circ Shock. 1992;38:165\u201372.","journal-title":"Circ Shock"},{"key":"6109_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2433-6","volume":"23","author":"D De Backer","year":"2019","unstructured":"De Backer D, Foulon P. Minimizing catecholamines and optimizing perfusion. Crit Care. 2019;23:149. https:\/\/doi.org\/10.1186\/s13054-019-2433-6.","journal-title":"Crit Care"},{"key":"6109_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13613-023-01101-4","volume":"13","author":"AK Khanna","year":"2023","unstructured":"Khanna AK, Kinoshita T, Natarajan A, Schwager E, Linn DD, Dong J, et al. Association of systolic, diastolic, mean, and pulse pressure with morbidity and mortality in septic ICU patients: a nationwide observational study. Ann Intensive Care. 2023;13:9. https:\/\/doi.org\/10.1186\/s13613-023-01101-4.","journal-title":"Ann Intensive Care"},{"issue":"6","key":"6109_CR9","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1164\/ajrccm.160.6.9808019","volume":"160","author":"P Datta","year":"1999","unstructured":"Datta P, Magder S. Hemodynamic response to norepinephrine with and without inhibition of nitric oxide synthase in porcine endotoxemia. Am J Respir Crit Care Med. 1999;160(6):1987\u201393. https:\/\/doi.org\/10.1164\/ajrccm.160.6.9808019.","journal-title":"Am J Respir Crit Care Med"},{"key":"6109_CR10","doi-asserted-by":"publisher","first-page":"e2305","DOI":"10.1097\/ccm.0000000000006805","volume":"53","author":"E Sanchez","year":"2025","unstructured":"Sanchez E, Taha A, Tolba Y, Hernandez G, Pinsky MR. Assessment of tissue perfusion pressure in patients with septic shock: beyond mean arterial pressure. Crit Care Med. 2025;53:e2305\u201317. https:\/\/doi.org\/10.1097\/ccm.0000000000006805.","journal-title":"Crit Care Med"},{"key":"6109_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2026.155485","volume":"93","author":"R Castro","year":"2026","unstructured":"Castro R, Retamal J, Hern\u00e1ndez G, Kattan E, Pinsky MR. Critical closing pressure in the circulation: understanding the vascular waterfall phenomenon. J Crit Care. 2026;93:155485. https:\/\/doi.org\/10.1016\/j.jcrc.2026.155485.","journal-title":"J Crit Care"},{"key":"6109_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-023-00539-x","volume":"11","author":"S Andrei","year":"2023","unstructured":"Andrei S, Bar S, Nguyen M, Bouhemad B, Guinot P-G. Effect of norepinephrine on the vascular waterfall and tissue perfusion in vasoplegic hypotensive patients: a prospective, observational, applied physiology study in cardiac surgery. Intensive Care Med Exp. 2023;11:52. https:\/\/doi.org\/10.1186\/s40635-023-00539-x.","journal-title":"Intensive Care Med Exp"},{"key":"6109_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-021-00587-z","volume":"10","author":"Z Liu","year":"2022","unstructured":"Liu Z, Pan C, Liu J, Liu H, Xie H. Esmolol response in septic shock patients in relation to vascular waterfall phenomenon measured by critical closure pressure and mean systemic filling pressure: a prospective observational study. J Intensive Care. 2022;10:1. https:\/\/doi.org\/10.1186\/s40560-021-00587-z.","journal-title":"J Intensive Care"},{"key":"6109_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-025-00828-7","volume":"13","author":"R Castro","year":"2025","unstructured":"Castro R, Kattan E, Retamal J, Hern\u00e1ndez G, Pinsky MR. Venous congestion from a vascular waterfall perspective: reframing congestion as a dynamic Starling resistor phenomenon. Intensive Care Med Exp. 2025;13:119. https:\/\/doi.org\/10.1186\/s40635-025-00828-7.","journal-title":"Intensive Care Med Exp"},{"key":"6109_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/cc9207","volume":"14","author":"O Hamzaoui","year":"2010","unstructured":"Hamzaoui O, Georger J-F, Monnet X, Ksouri H, Maizel J, Richard C, et al. Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension. Crit Care. 2010;14:R142. https:\/\/doi.org\/10.1186\/cc9207.","journal-title":"Crit Care"},{"key":"6109_CR16","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1097\/ccm.0b013e318260c6c3","volume":"40","author":"R Persichini","year":"2012","unstructured":"Persichini R, Silva S, Teboul J-L, Jozwiak M, Chemla D, Richard C, et al. Effects of norepinephrine on mean systemic pressure and venous return in human septic shock. Crit Care Med. 2012;40:3146\u201353. https:\/\/doi.org\/10.1097\/ccm.0b013e318260c6c3.","journal-title":"Crit Care Med"},{"key":"6109_CR17","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/ccm.0b013e318206d2a3","volume":"39","author":"X Monnet","year":"2011","unstructured":"Monnet X, Jabot J, Maizel J, Richard C, Teboul J-L. Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients. Crit Care Med. 2011;39:689\u201394. https:\/\/doi.org\/10.1097\/ccm.0b013e318206d2a3.","journal-title":"Crit Care Med"},{"key":"6109_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03711-5","volume":"25","author":"I Adda","year":"2021","unstructured":"Adda I, Lai C, Teboul J-L, Guerin L, Gavelli F, Monnet X. Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock. Crit Care. 2021;25:302. https:\/\/doi.org\/10.1186\/s13054-021-03711-5.","journal-title":"Crit Care"},{"key":"6109_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.bja.2017.11.065","volume":"120","author":"O Hamzaoui","year":"2018","unstructured":"Hamzaoui O, Jozwiak M, Geffriaud T, Sztrymf B, Prat D, Jacobs F, et al. Norepinephrine exerts an inotropic effect during the early phase of human septic shock. Br J Anaesth. 2018;120:517\u201324. https:\/\/doi.org\/10.1016\/j.bja.2017.11.065.","journal-title":"Br J Anaesth"},{"key":"6109_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1164\/rccm.200109-016oc","volume":"166","author":"D De Backer","year":"2002","unstructured":"De Backer D, Creteur J, Preiser J-C, Dubois M-J, Vincent J-L. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98\u2013104. https:\/\/doi.org\/10.1164\/rccm.200109-016oc.","journal-title":"Am J Respir Crit Care Med"},{"key":"6109_CR21","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1097\/01.ccm.0000138558.16257.3f","volume":"32","author":"Y Sakr","year":"2004","unstructured":"Sakr Y, Dubois M-J, De Backer D, Creteur J, Vincent J-L. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32:1825\u201331. https:\/\/doi.org\/10.1097\/01.ccm.0000138558.16257.3f.","journal-title":"Crit Care Med"},{"key":"6109_CR22","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1007\/s00134-008-1193-6","volume":"34","author":"S Trzeciak","year":"2008","unstructured":"Trzeciak S, McCoy JV, Dellinger RP, Arnold RC, Rizzuto M, Abate NL, et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med. 2008;34:2210\u20137. https:\/\/doi.org\/10.1007\/s00134-008-1193-6.","journal-title":"Intensive Care Med"},{"key":"6109_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1842-7","volume":"21","author":"NAR Vellinga","year":"2017","unstructured":"Vellinga NAR, Boerma EC, Koopmans M, Donati A, Dubin A, Shapiro NI, et al. Mildly elevated lactate levels are associated with microcirculatory flow abnormalities and increased mortality: a microSOAP post hoc analysis. Crit Care. 2017;21:255. https:\/\/doi.org\/10.1186\/s13054-017-1842-7.","journal-title":"Crit Care"},{"key":"6109_CR24","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s00134-010-2013-3","volume":"36","author":"J-F Georger","year":"2010","unstructured":"Georger J-F, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul J-L. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive Care Med. 2010;36:1882\u20139. https:\/\/doi.org\/10.1007\/s00134-010-2013-3.","journal-title":"Intensive Care Med"},{"key":"6109_CR25","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/ccm.0b013e31823dae59","volume":"40","author":"VSK Edul","year":"2012","unstructured":"Edul VSK, Enrico C, Laviolle B, Vazquez AR, Ince C, Dubin A. Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock. Crit Care Med. 2012;40:1443\u20138. https:\/\/doi.org\/10.1097\/ccm.0b013e31823dae59.","journal-title":"Crit Care Med"},{"key":"6109_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/shk.0b013e3181c6be04","volume":"33","author":"A Spanos","year":"2010","unstructured":"Spanos A, Jhanji S, Vivian-Smith A, Harris T, Pearse RM. Early microvascular changes in sepsis and severe sepsis. Shock. 2010;33:387\u201391. https:\/\/doi.org\/10.1097\/shk.0b013e3181c6be04.","journal-title":"Shock"},{"key":"6109_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2240-5","volume":"22","author":"MJ Massey","year":"2018","unstructured":"Massey MJ, Hou PC, Filbin M, Wang H, Ngo L, Huang DT, et al. Microcirculatory perfusion disturbances in septic shock: results from the ProCESS trial. Crit Care. 2018;22:308. https:\/\/doi.org\/10.1186\/s13054-018-2240-5.","journal-title":"Crit Care"},{"key":"6109_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s13546-013-0663-1","volume":"22","author":"D De Backer","year":"2013","unstructured":"De Backer D. Interactions macro- et microcirculatoires dans le choc. R\u00e9animation. 2013;22:191\u20135. https:\/\/doi.org\/10.1007\/s13546-013-0663-1.","journal-title":"R\u00e9animation"},{"key":"6109_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/cc10462","volume":"15","author":"A Thooft","year":"2011","unstructured":"Thooft A, Favory R, Salgado DR, Taccone FS, Donadello K, De Backer D, et al. Effects of changes in arterial pressure on organ perfusion during septic shock. Crit Care. 2011;15:R222. https:\/\/doi.org\/10.1186\/cc10462.","journal-title":"Crit Care"},{"key":"6109_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/cc8167","volume":"13","author":"MW D\u00fcnser","year":"2009","unstructured":"D\u00fcnser MW, Ruokonen E, Pettil\u00e4 V, Ulmer H, Torgersen C, Schmittinger CA, et al. Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial. Crit Care. 2009;13:R181. https:\/\/doi.org\/10.1186\/cc8167.","journal-title":"Crit Care"},{"key":"6109_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0532-y","volume":"18","author":"X Bai","year":"2014","unstructured":"Bai X, Yu W, Ji W, Lin Z, Tan S, Duan K, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014;18:532. https:\/\/doi.org\/10.1186\/s13054-014-0532-y.","journal-title":"Crit Care"},{"key":"6109_CR32","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jama.2017.2841","volume":"317","author":"E Vail","year":"2017","unstructured":"Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld G, Wunsch H. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA. 2017;317:1433. https:\/\/doi.org\/10.1001\/jama.2017.2841.","journal-title":"JAMA"},{"key":"6109_CR33","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","volume":"34","author":"JA Myburgh","year":"2008","unstructured":"Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008;34:2226. https:\/\/doi.org\/10.1007\/s00134-008-1219-0.","journal-title":"Intensive Care Med"},{"key":"6109_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/s0140-6736(07)61344-0","volume":"370","author":"D Annane","year":"2007","unstructured":"Annane D, Vignon P, Renault A, Bollaert P-E, Charpentier C, Martin C, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007;370:676\u201384. https:\/\/doi.org\/10.1016\/s0140-6736(07)61344-0.","journal-title":"Lancet"},{"key":"6109_CR35","first-page":"1","volume":"2026","author":"HC Prescott","year":"2026","unstructured":"Prescott HC, Antonelli M, Alhazzani W, M\u00f8ller MH, Alshamsi F, Azevedo LCP, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock. Intensive Care Med. 2026;2026:1\u201373.","journal-title":"Intensive Care Med"},{"key":"6109_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000005885","author":"GA Ospina-Tasc\u00f3n","year":"2023","unstructured":"Ospina-Tasc\u00f3n GA, Aldana JL, Mar\u00edn AFG, Calder\u00f3n-Tapia LE, Marulanda A, Escobar EP, et al. Immediate norepinephrine in endotoxic shock: effects on regional and microcirculatory flow. Crit Care Med. 2023. https:\/\/doi.org\/10.1097\/ccm.0000000000005885.","journal-title":"Crit Care Med"},{"key":"6109_CR37","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034oc","volume":"199","author":"C Permpikul","year":"2019","unstructured":"Permpikul C, Tongyoo S, Viarasilpa T, Trainarongsakul T, Chakorn T, Udompanturak S. Early use of Norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med. 2019;199:1097\u2013105. https:\/\/doi.org\/10.1164\/rccm.201806-1034oc.","journal-title":"Am J Respir Crit Care Med"},{"key":"6109_CR38","doi-asserted-by":"publisher","unstructured":"National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network; Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, et al. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension. N Engl J Med. 2023;388:499\u2013510. https:\/\/doi.org\/10.1056\/nejmoa2212663","DOI":"10.1056\/nejmoa2212663"},{"key":"6109_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13054-024-05019-6","volume":"28","author":"A Jorda","year":"2024","unstructured":"Jorda A, Douglas IS, Staudinger T, Heinz G, Bergmann F, Oberbauer R, et al. Fluid management for sepsis-induced hypotension in patients with advanced chronic kidney disease: a secondary analysis of the CLOVERS trial. Crit Care. 2024;28:231. https:\/\/doi.org\/10.1186\/s13054-024-05019-6.","journal-title":"Crit Care"},{"key":"6109_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13613-022-01022-8","volume":"12","author":"X Monnet","year":"2022","unstructured":"Monnet X, Shi R, Teboul J-L. Prediction of fluid responsiveness. What\u2019s new? Ann Intensive Care. 2022;12:46. https:\/\/doi.org\/10.1186\/s13613-022-01022-8.","journal-title":"Ann Intensive Care"},{"key":"6109_CR41","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.21037\/jtd.2019.12.50","volume":"12","author":"O Hamzaoui","year":"2020","unstructured":"Hamzaoui O, Shi R. Early norepinephrine use in septic shock. J Thorac Dis. 2020;12:S72\u20137. https:\/\/doi.org\/10.21037\/jtd.2019.12.50.","journal-title":"J Thorac Dis"},{"key":"6109_CR42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13613-020-00658-8","volume":"10","author":"GA Ospina-Tasc\u00f3n","year":"2020","unstructured":"Ospina-Tasc\u00f3n GA, Teboul J-L, Hernandez G, Alvarez I, S\u00e1nchez-Ortiz AI, Calder\u00f3n-Tapia LE, et al. Diastolic shock index and clinical outcomes in patients with septic shock. Ann Intensive Care. 2020;10:41. https:\/\/doi.org\/10.1186\/s13613-020-00658-8.","journal-title":"Ann Intensive Care"},{"key":"6109_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-025-01454-y","volume":"15","author":"A Goury","year":"2025","unstructured":"Goury A, Djerada Z, Hernandez G, Kattan E, Griffon R, Ospina-Tascon G, et al. Ability of diastolic arterial pressure to better characterize the severity of septic shock when adjusted for heart rate and norepinephrine dose. Ann Intensive Care. 2025;15:43. https:\/\/doi.org\/10.1186\/s13613-025-01454-y.","journal-title":"Ann Intensive Care"},{"key":"6109_CR44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.chest.2023.08.019","volume":"165","author":"JR Yerke","year":"2024","unstructured":"Yerke JR, Mireles-Cabodevila E, Chen AY, Bass SN, Reddy AJ, Bauer SR, et al. Peripheral Administration of Norepinephrine: A Prospective Observational Study. Chest. 2024;165:348\u201355. https:\/\/doi.org\/10.1016\/j.chest.2023.08.019.","journal-title":"Chest"},{"key":"6109_CR45","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/01.ccm.0000910748.92246.0c","volume":"51","author":"S Powell","year":"2023","unstructured":"Powell S, Faust A, George S. Effect of peripherally infused norepinephrine on reducing central venous catheter utilization (abstract). Crit Care Med. 2023;51:625. https:\/\/doi.org\/10.1097\/01.ccm.0000910748.92246.0c.","journal-title":"Crit Care Med"},{"key":"6109_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.chstcc.2025.100195","volume":"3","author":"LM Groetzinger","year":"2025","unstructured":"Groetzinger LM, Williams J, Svec S, Donahoe MP, Lamberty PE, Barbash IJ. Association of peripheral norepinephrine protocol implementation on central venous catheter placement in a medical ICU. CHEST Crit Care. 2025;3:100195. https:\/\/doi.org\/10.1016\/j.chstcc.2025.100195.","journal-title":"CHEST Crit Care"},{"key":"6109_CR47","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.29148","volume":"8","author":"ES Munroe","year":"2025","unstructured":"Munroe ES, Co IN, Douglas I, Hyzy R, Khan A, Nelson K, et al. Peripheral vasopressor use in early sepsis-induced hypotension. JAMA Netw Open. 2025;8:e2529148. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.29148.","journal-title":"JAMA Netw Open"},{"key":"6109_CR48","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/eurheartj\/ehaf340","volume":"46","author":"N A\u00efssaoui","year":"2025","unstructured":"A\u00efssaoui N, Boissier F, Chew M, Singer M, Vignon P. Sepsis-induced cardiomyopathy. Eur Heart J. 2025;46:3339\u201353. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf340.","journal-title":"Eur Heart J"},{"key":"6109_CR49","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1097\/ccm.0b013e318174db05","volume":"36","author":"A Vieillard-Baron","year":"2008","unstructured":"Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 2008;36:1701\u20136. https:\/\/doi.org\/10.1097\/ccm.0b013e318174db05.","journal-title":"Crit Care Med"},{"key":"6109_CR50","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.chest.2025.08.013","volume":"168","author":"R Sato","year":"2025","unstructured":"Sato R, Sanfilippo F, Lanspa M, Duggal A, Dugar S. Sepsis-induced cardiomyopathy: mechanism, prevalence, assessment, prognosis, and management. Chest. 2025;168:1383\u201394. https:\/\/doi.org\/10.1016\/j.chest.2025.08.013.","journal-title":"Chest"},{"key":"6109_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/shk.0b013e318289376b","volume":"39","author":"CA Schmittinger","year":"2013","unstructured":"Schmittinger CA, D\u00fcnser MW, Torgersen C, Luckner G, Lorenz I, Schmid S, et al. Histologic Pathologies of the Myocardium in Septic Shock. Shock. 2013;39:329\u201335. https:\/\/doi.org\/10.1097\/shk.0b013e318289376b.","journal-title":"Shock"},{"key":"6109_CR52","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/circulationaha.112.111591","volume":"126","author":"H Paur","year":"2012","unstructured":"Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O\u2019Gara P, et al. High levels of circulating epinephrine trigger apical cardiodepression in a \u03b22-Adrenergic Receptor\/Gi-Dependent manner. Circulation. 2012;126:697\u2013706. https:\/\/doi.org\/10.1161\/circulationaha.112.111591.","journal-title":"Circulation"},{"key":"6109_CR53","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/circulationaha.121.055854","volume":"145","author":"T Singh","year":"2022","unstructured":"Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation. 2022;145:1002\u201319. https:\/\/doi.org\/10.1161\/circulationaha.121.055854.","journal-title":"Circulation"},{"key":"6109_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04161-3","volume":"26","author":"B Garcia","year":"2022","unstructured":"Garcia B, Su F, Dewachter L, Favory R, Khaldi A, Moiroux-Sahraoui A, et al. Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock. Crit Care. 2022;26:281. https:\/\/doi.org\/10.1186\/s13054-022-04161-3.","journal-title":"Crit Care"},{"key":"6109_CR55","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/shk.0000000000002109","volume":"59","author":"EJ See","year":"2023","unstructured":"See EJ, Clapham C, Liu J, Khasin M, Liskaser G, Chan JW, et al. A pilot study of angiotensin II as primary vasopressor in critically ill adults with vasodilatory hypotension: the ARAMIS study. Shock. 2023;59:691\u20136. https:\/\/doi.org\/10.1097\/shk.0000000000002109.","journal-title":"Shock"},{"key":"6109_CR56","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201603-0618oc","volume-title":"Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis","author":"PMC Klein Klouwenberg","year":"2016","unstructured":"Klein Klouwenberg PMC, Frencken JF, Kuipers S, Ong DSY, Peelen LM, van Vught LA, et al. Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study: Am J Respir Crit Care Med; 2016. https:\/\/doi.org\/10.1164\/rccm.201603-0618oc."},{"key":"6109_CR57","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1001\/jama.2018.4528","volume":"319","author":"WF McIntyre","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, et al. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis. JAMA. 2018;319:1889\u2013900. https:\/\/doi.org\/10.1001\/jama.2018.4528.","journal-title":"JAMA"},{"key":"6109_CR58","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1056\/nejmoa1312173","volume":"370","author":"P Asfar","year":"2014","unstructured":"Asfar P, Meziani F, Hamel J-F, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583\u201393. https:\/\/doi.org\/10.1056\/nejmoa1312173.","journal-title":"N Engl J Med"},{"key":"6109_CR59","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/0026-0495(80)90025-6","volume":"29","author":"RA Rizza","year":"1980","unstructured":"Rizza RA, Cryer PE, Haymond MW, Gerich JE. Adrenergic mechanisms of catecholamine action on glucose homeostasis in man. Metabolism. 1980;29:1155\u201363. https:\/\/doi.org\/10.1016\/0026-0495(80)90025-6.","journal-title":"Metabolism"},{"key":"6109_CR60","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/dmrr.1212","volume":"27","author":"N Khoury","year":"2011","unstructured":"Khoury N, McGill JB. Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine. Diabetes Metab Res Rev. 2011;27:604\u20138. https:\/\/doi.org\/10.1002\/dmrr.1212.","journal-title":"Diabetes Metab Res Rev"},{"key":"6109_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/cc12514","volume":"17","author":"PE Marik","year":"2013","unstructured":"Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013;17:305. https:\/\/doi.org\/10.1186\/cc12514.","journal-title":"Crit Care"},{"key":"6109_CR62","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1172\/jci106978","volume":"51","author":"JK Kjekshus","year":"1972","unstructured":"Kjekshus JK, Mj\u00f8s OD. Effect of free fatty acids on myocardial function and metabolism in the ischemic dog heart. J Clin Invest. 1972;51:1767\u201376. https:\/\/doi.org\/10.1172\/jci106978.","journal-title":"J Clin Invest"},{"key":"6109_CR63","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.2174\/138920012803762729","volume":"13","author":"S Savary","year":"2012","unstructured":"Savary S, Trompier D, Andreoletti P, Le Borgne F, Demarquoy J, Lizard G. Fatty acids-induced lipotoxicity and inflammation. Curr Drug Metab. 2012;13:1358\u201370. https:\/\/doi.org\/10.2174\/138920012803762729.","journal-title":"Curr Drug Metab"},{"key":"6109_CR64","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.mito.2014.05.007","volume":"17","author":"M Adeva-Andany","year":"2014","unstructured":"Adeva-Andany M, L\u00f3pez-Oj\u00e9n M, Funcasta-Calder\u00f3n R, Ameneiros-Rodr\u00edguez E, Donapetry-Garc\u00eda C, Vila-Altesor M, et al. Comprehensive review on lactate metabolism in human health. Mitochondrion. 2014;17:76\u2013100. https:\/\/doi.org\/10.1016\/j.mito.2014.05.007.","journal-title":"Mitochondrion"},{"key":"6109_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0896-7","volume":"19","author":"A Kimmoun","year":"2015","unstructured":"Kimmoun A, Novy E, Auchet T, Ducrocq N, Levy B. Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside. Crit Care. 2015;19:175. https:\/\/doi.org\/10.1186\/s13054-015-0896-7.","journal-title":"Crit Care"},{"key":"6109_CR66","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13054-025-05462-z","volume":"29","author":"A Pierre","year":"2025","unstructured":"Pierre A, Favory R, Bourel C, Howsam M, Romien R, Lancel S, et al. Muscle weakness after critical illness: unravelling biological mechanisms and clinical hurdles. Crit Care. 2025;29:248. https:\/\/doi.org\/10.1186\/s13054-025-05462-z.","journal-title":"Crit Care"},{"key":"6109_CR67","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.chest.2018.07.016","volume":"154","author":"KS Wolfe","year":"2018","unstructured":"Wolfe KS, Patel BK, MacKenzie EL, Giovanni SP, Pohlman AS, Churpek MM, et al. Impact of Vasoactive Medications on ICU-Acquired Weakness in Mechanically Ventilated Patients. Chest. 2018;154:781\u20137. https:\/\/doi.org\/10.1016\/j.chest.2018.07.016.","journal-title":"Chest"},{"key":"6109_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1474-8673.2003.00280.x","volume":"23","author":"F Mignini","year":"2003","unstructured":"Mignini F, Streccioni V, Amenta F. Autonomic innervation of immune organs and neuroimmune modulation. Auton Autacoid Pharmacol. 2003;23:1\u201325.","journal-title":"Auton Autacoid Pharmacol"},{"key":"6109_CR69","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/cc8026","volume":"13","author":"E de Montmollin","year":"2009","unstructured":"de Montmollin E, Aboab J, Mansart A, Annane D. Bench-to-bedside review: \u03b2-adrenergic modulation in sepsis. Crit Care. 2009;13:230. https:\/\/doi.org\/10.1186\/cc8026.","journal-title":"Crit Care"},{"key":"6109_CR70","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1164\/rccm.201604-0862cp","volume":"194","author":"RF Stolk","year":"2016","unstructured":"Stolk RF, van der Poll T, Angus DC, van der Hoeven JG, Pickkers P, Kox M. Potentially inadvertent immunomodulation: norepinephrine use in sepsis. Am J Respir Crit Care Med. 2016;194:550\u20138. https:\/\/doi.org\/10.1164\/rccm.201604-0862cp.","journal-title":"Am J Respir Crit Care Med"},{"key":"6109_CR71","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1128\/cdli.3.4.423-428.1996","volume":"3","author":"C Wenisch","year":"1996","unstructured":"Wenisch C, Parschalk B, Weiss A, Zedwitz-Liebenstein K, Hahsler B, Wenisch H, et al. High-dose catecholamine treatment decreases polymorphonuclear leukocyte phagocytic capacity and reactive oxygen production. Clin Diagn Lab Immunol. 1996;3:423\u20138. https:\/\/doi.org\/10.1128\/cdli.3.4.423-428.1996.","journal-title":"Clin Diagn Lab Immunol"},{"key":"6109_CR72","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0031-6997(24)01510-2","volume":"53","author":"AP Kohm","year":"2001","unstructured":"Kohm AP, Sanders VM. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev. 2001;53:487\u2013525.","journal-title":"Pharmacol Rev"},{"key":"6109_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000343099","volume":"20","author":"H-W Huang","year":"2013","unstructured":"Huang H-W, Tang J-L, Han X-H, Peng Y-P, Qiu Y-H. Lymphocyte-derived catecholamines induce a shift of Th1\/Th2 balance toward Th2 polarization. NeuroImmunoModulation. 2013;20:1\u20138. https:\/\/doi.org\/10.1159\/000343099.","journal-title":"NeuroImmunoModulation"},{"key":"6109_CR74","doi-asserted-by":"publisher","first-page":"e707","DOI":"10.1097\/ccm.0000000000005503","volume":"50","author":"M Durand","year":"2022","unstructured":"Durand M, Hagimont E, Louis H, Asfar P, Frippiat J-P, Singer M, et al. The \u03b21-adrenergic receptor contributes to sepsis-induced immunosuppression through modulation of regulatory T-cell inhibitory function. Crit Care Med. 2022;50:e707\u201318. https:\/\/doi.org\/10.1097\/ccm.0000000000005503.","journal-title":"Crit Care Med"},{"key":"6109_CR75","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/s0140-6736(03)12231-3","volume":"361","author":"M Lyte","year":"2003","unstructured":"Lyte M, Freestone PP, Neal CP, Olson BA, Haigh RD, Bayston R, et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet. 2003;361:130\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(03)12231-3.","journal-title":"Lancet"},{"key":"6109_CR76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1574-6968.2006.00619.x","volume":"269","author":"PPE Freestone","year":"2007","unstructured":"Freestone PPE, Haigh RD, Lyte M. Specificity of catecholamine-induced growth in Escherichia coli O157:H7, Salmonella enterica and Yersinia enterocolitica. FEMS Microbiol Lett. 2007;269:221\u20138.","journal-title":"FEMS Microbiol Lett"},{"key":"6109_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-14-180","volume":"14","author":"S Sandrini","year":"2014","unstructured":"Sandrini S, Alghofaili F, Freestone P, Yesilkaya H. Host stress hormone norepinephrine stimulates pneumococcal growth, biofilm formation and virulence gene expression. BMC Microbiol. 2014;14:180. https:\/\/doi.org\/10.1186\/1471-2180-14-180.","journal-title":"BMC Microbiol"},{"key":"6109_CR78","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jns.2006.10.001","volume":"252","author":"\u00c1 Chamorro","year":"2007","unstructured":"Chamorro \u00c1, Amaro S, Vargas M, Obach V, Cervera \u00c1, G\u00f3mez-Choco M, et al. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci. 2007;252:29\u201335. https:\/\/doi.org\/10.1016\/j.jns.2006.10.001.","journal-title":"J Neurol Sci"},{"key":"6109_CR79","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.202002-0339oc","volume":"202","author":"RF Stolk","year":"2020","unstructured":"Stolk RF, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden T, et al. Norepinephrine dysregulates the immune response and compromises host defense during sepsis. Am J Respir Crit Care Med. 2020;202:830\u201342. https:\/\/doi.org\/10.1164\/rccm.202002-0339oc.","journal-title":"Am J Respir Crit Care Med"},{"key":"6109_CR80","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00134-018-5242-5","volume":"44","author":"D Annane","year":"2018","unstructured":"Annane D, Ouanes-Besbes L, De Backer D, Du B, Gordon AC, Hern\u00e1ndez G, et al. A global perspective on vasoactive agents in shock. Intensive Care Med. 2018;44:833\u201346. https:\/\/doi.org\/10.1007\/s00134-018-5242-5.","journal-title":"Intensive Care Med"},{"key":"6109_CR81","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00134-016-4249-z","volume":"42","author":"DT Andreis","year":"2016","unstructured":"Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 2016;42:1387\u201397. https:\/\/doi.org\/10.1007\/s00134-016-4249-z.","journal-title":"Intensive Care Med"},{"key":"6109_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05717-9","volume":"29","author":"M Reinikainen","year":"2025","unstructured":"Reinikainen M, Delamarre L, Reintam Blaser A, Hollenberg SM, Lobo SM, Rezende E, et al. Association of noradrenaline dose with mortality in critically ill patients: a systematic review and dose-response meta-analysis. Crit Care. 2025;29:498. https:\/\/doi.org\/10.1186\/s13054-025-05717-9.","journal-title":"Crit Care"},{"key":"6109_CR83","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13613-018-0448-9","volume":"8","author":"J-L Vincent","year":"2018","unstructured":"Vincent J-L, Nielsen ND, Shapiro NI, Gerbasi ME, Grossman A, Doroff R, et al. Mean arterial pressure and mortality in patients with distributive shock: a retrospective analysis of the MIMIC-III database. Ann Intensive Care. 2018;8:107. https:\/\/doi.org\/10.1186\/s13613-018-0448-9.","journal-title":"Ann Intensive Care"},{"key":"6109_CR84","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13613-022-01053-1","volume":"12","author":"N Fage","year":"2022","unstructured":"Fage N, Demiselle J, Seegers V, Merdji H, Grelon F, M\u00e9garbane B, et al. Effects of mean arterial pressure target on mottling and arterial lactate normalization in patients with septic shock: a post hoc analysis of the SEPSISPAM randomized trial. Ann Intensive Care. 2022;12:78. https:\/\/doi.org\/10.1186\/s13613-022-01053-1.","journal-title":"Ann Intensive Care"},{"key":"6109_CR85","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00134-017-5016-5","volume":"44","author":"F Lamontagne","year":"2018","unstructured":"Lamontagne F, Day AG, Meade MO, Cook DJ, Guyatt GH, Hylands M, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy in septic and vasodilatory shock. Intensive Care Med. 2018;44:12\u201321. https:\/\/doi.org\/10.1007\/s00134-017-5016-5.","journal-title":"Intensive Care Med"},{"key":"6109_CR86","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1001\/jama.2020.0930","volume":"323","author":"F Lamontagne","year":"2020","unstructured":"Lamontagne F, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al. Effect of reduced exposure to vasopressors on 90-Day mortality in older critically ill patients with vasodilatory hypotension. JAMA. 2020;323:938\u201349. https:\/\/doi.org\/10.1001\/jama.2020.0930.","journal-title":"JAMA"},{"key":"6109_CR87","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00134-025-07910-4","volume":"51","author":"A Endo","year":"2025","unstructured":"Endo A, Yamakawa K, Tagami T, Umemura Y, Wada T, Yamamoto R, et al. Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial. Intensive Care Med. 2025;51:883\u201392. https:\/\/doi.org\/10.1007\/s00134-025-07910-4.","journal-title":"Intensive Care Med"},{"key":"6109_CR88","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2025.20402","volume":"334","author":"F P\u00e1lizas","year":"2025","unstructured":"ANDROMEDA-SHOCK-2 Investigators (LIVEN) for the Spanish Society of Anesthesiology, Reanimation and Pain Therapy (SEDAR) and Latin American Intensive Care Network, P\u00e1lizas F, Lattanzio B, Durandal N, Alonso ME, Duque J, et al. Personalized hemodynamic resuscitation targeting capillary refill time in early septic shock. JAMA. 2025;334:1988\u201399. https:\/\/doi.org\/10.1001\/jama.2025.20402.","journal-title":"JAMA"},{"key":"6109_CR89","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1007\/s00134-018-5401-8","volume":"44","author":"J-L Vincent","year":"2018","unstructured":"Vincent J-L. How I treat septic shock. Intensive Care Med. 2018;44:2242\u20134. https:\/\/doi.org\/10.1007\/s00134-018-5401-8.","journal-title":"Intensive Care Med"},{"key":"6109_CR90","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-04255-y","volume":"26","author":"D De Backer","year":"2022","unstructured":"De Backer D, Cecconi M, Chew MS, Hajjar L, Monnet X, Ospina-Tasc\u00f3n GA, et al. A plea for personalization of the hemodynamic management of septic shock. Crit Care. 2022;26:372. https:\/\/doi.org\/10.1186\/s13054-022-04255-y.","journal-title":"Crit Care"},{"key":"6109_CR91","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1001\/jama.2019.0071","volume":"321","author":"G Hern\u00e1ndez","year":"2019","unstructured":"Hern\u00e1ndez G, Ospina-Tasc\u00f3n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-Day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321:654. https:\/\/doi.org\/10.1001\/jama.2019.0071.","journal-title":"JAMA"},{"key":"6109_CR92","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1164\/rccm.201905-0968oc","volume":"201","author":"FG Zampieri","year":"2020","unstructured":"Zampieri FG, Damiani LP, Bakker J, Ospina-Tasc\u00f3n GA, Castro R, Cavalcanti AB, et al. Effects of a resuscitation strategy targeting peripheral perfusion status versus serum lactate levels among patients with septic shock. A Bayesian reanalysis of the ANDROMEDA-SHOCK trial. Am J Respir Crit Care Med. 2020;201:423\u20139. https:\/\/doi.org\/10.1164\/rccm.201905-0968oc.","journal-title":"Am J Respir Crit Care Med"},{"key":"6109_CR93","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1097\/01.ccm.0000063046.82359.4a","volume":"31","author":"T Sharshar","year":"2003","unstructured":"Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med. 2003;31:1752\u20138. https:\/\/doi.org\/10.1097\/01.ccm.0000063046.82359.4a.","journal-title":"Crit Care Med"},{"key":"6109_CR94","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/nejmoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, Gordon AC, H\u00e9bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877\u201387. https:\/\/doi.org\/10.1056\/nejmoa067373.","journal-title":"N Engl J Med"},{"key":"6109_CR95","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/ccm.0000000000005317","volume":"50","author":"GL Sacha","year":"2022","unstructured":"Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock. Crit Care Med. 2022;50:614\u201323. https:\/\/doi.org\/10.1097\/ccm.0000000000005317.","journal-title":"Crit Care Med"},{"key":"6109_CR96","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509\u201318. https:\/\/doi.org\/10.1001\/jama.2016.10485.","journal-title":"JAMA"},{"key":"6109_CR97","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/ccm.0000000000004023","volume":"47","author":"LA Hajjar","year":"2019","unstructured":"Hajjar LA, Zambolim C, Belletti A, de Almeida JP, Gordon AC, Oliveira G, et al. Vasopressin versus norepinephrine for the management of septic shock in cancer patients: the VANCS II randomized clinical trial. Crit Care Med. 2019;47:1743\u201350. https:\/\/doi.org\/10.1097\/ccm.0000000000004023.","journal-title":"Crit Care Med"},{"key":"6109_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05540-2","volume":"29","author":"Q Lajoye","year":"2025","unstructured":"Lajoye Q, Orieux A, Boyer A, Prevel R, Jozwiak M. Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise? Crit Care. 2025;29:333. https:\/\/doi.org\/10.1186\/s13054-025-05540-2.","journal-title":"Crit Care"},{"key":"6109_CR99","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1378\/chest.11-2604","volume":"142","author":"AC Gordon","year":"2012","unstructured":"Gordon AC, Wang N, Walley KR, Ashby D, Russell JA. The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock. Chest. 2012;142:593\u2013605. https:\/\/doi.org\/10.1378\/chest.11-2604.","journal-title":"Chest"},{"key":"6109_CR100","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1001\/jama.2025.3046","volume":"333","author":"A Kalimouttou","year":"2025","unstructured":"Kalimouttou A, Kennedy JN, Feng J, Singh H, Saria S, Angus DC, et al. Optimal vasopressin initiation in septic shock. JAMA. 2025;333:1688\u201398. https:\/\/doi.org\/10.1001\/jama.2025.3046.","journal-title":"JAMA"},{"key":"6109_CR101","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13054-025-05505-5","volume":"29","author":"M Jozwiak","year":"2025","unstructured":"Jozwiak M, Cousin VL, De Backer D, Malbrain MLNG, Monnet X, Messina A, et al. Vasopressin use across shock states: international insights from an international ESICM-endorsed survey: the PRESS Survey. Crit Care. 2025;29:273. https:\/\/doi.org\/10.1186\/s13054-025-05505-5.","journal-title":"Crit Care"},{"key":"6109_CR102","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1177\/08850666221081836","volume":"37","author":"ND Jakowenko","year":"2022","unstructured":"Jakowenko ND, Murata J, Kopp BJ, Erstad BL. Influence of timing and catecholamine requirements on vasopressin responsiveness in critically ill patients with septic shock. J Intensive Care Med. 2022;37:1512\u20139. https:\/\/doi.org\/10.1177\/08850666221081836.","journal-title":"J Intensive Care Med"},{"key":"6109_CR103","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04739-5","volume":"27","author":"B Garcia","year":"2023","unstructured":"Garcia B, Zarbock A, Bellomo R, Legrand M. The alternative renin\u2013angiotensin system in critically ill patients: pathophysiology and therapeutic implications. Crit Care. 2023;27:453. https:\/\/doi.org\/10.1186\/s13054-023-04739-5.","journal-title":"Crit Care"},{"key":"6109_CR104","doi-asserted-by":"publisher","DOI":"10.1097\/mcc.0000000000001092","author":"B Garcia","year":"2023","unstructured":"Garcia B, Zarbock A, Bellomo R, Legrand M. The role of renin-angiotensin system in sepsis-associated acute kidney injury: mechanisms and therapeutic implications. Curr Opin Crit Care. 2023. https:\/\/doi.org\/10.1097\/mcc.0000000000001092.","journal-title":"Curr Opin Crit Care"},{"key":"6109_CR105","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1681\/asn.2009070759","volume":"21","author":"J Peti-Peterdi","year":"2010","unstructured":"Peti-Peterdi J, Harris RC. Macula Densa sensing and signaling mechanisms of renin release. J Am Soc Nephrol. 2010;21:1093\u20136. https:\/\/doi.org\/10.1681\/asn.2009070759.","journal-title":"J Am Soc Nephrol"},{"key":"6109_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05120-w","volume":"28","author":"MC Chappell","year":"2024","unstructured":"Chappell MC, Schaich CL, Busse LW, Martin GS, Sevransky JE, Hinson JK, et al. Stronger association of intact angiotensinogen with mortality than lactate or renin in critical illness: post-hoc analysis from the VICTAS trial. Crit Care. 2024;28:333. https:\/\/doi.org\/10.1186\/s13054-024-05120-w.","journal-title":"Crit Care"},{"key":"6109_CR107","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1164\/rccm.201911-2172oc","volume":"202","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Forni LG, Busse LW, McCurdy MT, Ham KR, Boldt DW, et al. Renin and survival in patients given Angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial. Am J Respir Crit Care Med. 2020;202:1253\u201361. https:\/\/doi.org\/10.1164\/rccm.201911-2172oc.","journal-title":"Am J Respir Crit Care Med"},{"key":"6109_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2733-x","volume":"24","author":"R Bellomo","year":"2020","unstructured":"Bellomo R, Wunderink RG, Szerlip H, English SW, Busse LW, Deane AM, et al. Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock. Crit Care. 2020;24:43. https:\/\/doi.org\/10.1186\/s13054-020-2733-x.","journal-title":"Crit Care"},{"key":"6109_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-024-00638-3","volume":"12","author":"B Garcia","year":"2024","unstructured":"Garcia B, ter Schiphorst B, Santos K, Su F, Dewachter L, Vasques-N\u00f3voa F, et al. Inhibition of circulating dipeptidyl-peptidase 3 by Procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury. Intensive Care Med Exp. 2024;12:53. https:\/\/doi.org\/10.1186\/s40635-024-00638-3.","journal-title":"Intensive Care Med Exp"},{"key":"6109_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01325-y","volume":"14","author":"A Picod","year":"2024","unstructured":"Picod A, Garcia B, van Lier D, Pickkers P, Herpain A, Mebazaa A, et al. Impaired Angiotensin II signaling in septic shock. Ann Intensive Care. 2024;14:89. https:\/\/doi.org\/10.1186\/s13613-024-01325-y.","journal-title":"Ann Intensive Care"},{"key":"6109_CR111","doi-asserted-by":"publisher","DOI":"10.1097\/cce.0000000000001163","volume":"6","author":"B Garcia","year":"2024","unstructured":"Garcia B, ter Schiphorst B, Su F, Picod A, Ikenna-Uba T, Favory R, et al. Alterations in the Renin-Angiotensin System in experimental septic shock. Crit Care Explor. 2024;6:e1163. https:\/\/doi.org\/10.1097\/cce.0000000000001163.","journal-title":"Crit Care Explor"},{"key":"6109_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-021-03471-2","volume":"25","author":"A Blet","year":"2021","unstructured":"Blet A, Deniau B, Santos K, van Lier DPT, Azibani F, Wittebole X, et al. Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study. Crit Care. 2021;25:61. https:\/\/doi.org\/10.1186\/s13054-021-03471-2.","journal-title":"Crit Care"},{"key":"6109_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.07.047","author":"DE Leisman","year":"2021","unstructured":"Leisman DE, Fernandes TD, Bijol V, Abraham MN, Lehman JR, Taylor MD, et al. Impaired Angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury. Kidney Int. 2021. https:\/\/doi.org\/10.1016\/j.kint.2020.07.047.","journal-title":"Kidney Int"},{"key":"6109_CR114","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1056\/nejmoa1704154","volume":"377","author":"A Khanna","year":"2017","unstructured":"Khanna A, English SW, Wang XS, Ham K, Tumlin J, Szerlip H, et al. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017;377:419\u201330. https:\/\/doi.org\/10.1056\/nejmoa1704154.","journal-title":"N Engl J Med"},{"key":"6109_CR115","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1097\/ccm.0000000000003092","volume":"46","author":"JA Tumlin","year":"2018","unstructured":"Tumlin JA, Murugan R, Deane AM, Ostermann M, Busse LW, Ham KR, et al. Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous Angiotensin II. Crit Care Med. 2018;46:949\u201357. https:\/\/doi.org\/10.1097\/ccm.0000000000003092.","journal-title":"Crit Care Med"},{"key":"6109_CR116","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/shk.0000000000002481","volume":"63","author":"A Chaba","year":"2025","unstructured":"Chaba A, Zarbock A, Forni LG, H\u00e4stbacka J, Korneva E, Landoni G, et al. Angiotensin II for catecholamine-resistant vasodilatory shock in patients with acute kidney injury: a post hoc analysis of the ATHOS-3 trial. Shock. 2025;63:88\u201393. https:\/\/doi.org\/10.1097\/shk.0000000000002481.","journal-title":"Shock"},{"key":"6109_CR117","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1681\/asn.2021121605","volume":"33","author":"M Legrand","year":"2022","unstructured":"Legrand M, Bagshaw SM, Koyner JL, Schulman IH, Mathis MR, Bernholz J, et al. Optimizing the design and analysis of future AKI trials. J Am Soc Nephrol. 2022;33:1459\u201370. https:\/\/doi.org\/10.1681\/asn.2021121605.","journal-title":"J Am Soc Nephrol"},{"key":"6109_CR118","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00134-022-06708-y","volume":"48","author":"M Legrand","year":"2022","unstructured":"Legrand M, Zarbock A. Ten tips to optimize vasopressors use in the critically ill patient with hypotension. Intensive Care Med. 2022;48:736\u20139. https:\/\/doi.org\/10.1007\/s00134-022-06708-y.","journal-title":"Intensive Care Med"},{"key":"6109_CR119","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/hypertensionaha.123.21913","volume":"81","author":"A Picod","year":"2024","unstructured":"Picod A, Placier S, Genest M, Callebert J, Julian N, Zalc M, et al. Circulating Dipeptidyl Peptidase 3 Modulates Systemic and Renal Hemodynamics Through Cleavage of Angiotensin Peptides. Hypertension. 2024;81:927\u201335. https:\/\/doi.org\/10.1161\/hypertensionaha.123.21913.","journal-title":"Hypertension"},{"key":"6109_CR120","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/nejmoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S, et al. Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 2018;378:809\u201318. https:\/\/doi.org\/10.1056\/nejmoa1705716.","journal-title":"N Engl J Med"},{"key":"6109_CR121","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1515\/jccm-2015-0027","volume":"1","author":"A Schwartz","year":"2015","unstructured":"Schwartz A, Brotfain E, Koyfman L, Klein M. Cardiac Arrhythmias in a Septic ICU Population: A Review. J Crit Care Med. 2015;1:140\u20136. https:\/\/doi.org\/10.1515\/jccm-2015-0027.","journal-title":"J Crit Care Med"},{"key":"6109_CR122","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jama.2013.278477","volume":"310","author":"A Morelli","year":"2013","unstructured":"Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, et al. Effect of Heart Rate Control With Esmolol on Hemodynamic and Clinical Outcomes in Patients With Septic Shock: A Randomized Clinical Trial. JAMA. 2013;310:1683\u201391. https:\/\/doi.org\/10.1001\/jama.2013.278477.","journal-title":"JAMA"},{"key":"6109_CR123","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2023.20134","volume":"330","author":"T Whitehouse","year":"2023","unstructured":"Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D, et al. Landiolol and Organ Failure in Patients With Septic Shock. JAMA. 2023;330:1641\u201352. https:\/\/doi.org\/10.1001\/jama.2023.20134.","journal-title":"JAMA"},{"key":"6109_CR124","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00134-024-07587-1","volume":"50","author":"S Rehberg","year":"2024","unstructured":"Rehberg S, Frank S, \u010cern\u00fd V, Cihl\u00e1\u0159 R, Borgstedt R, Biancofiore G, et al. Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP). Intensive Care Med. 2024;50:1622\u201334. https:\/\/doi.org\/10.1007\/s00134-024-07587-1.","journal-title":"Intensive Care Med"},{"key":"6109_CR125","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.chest.2024.08.020","volume":"167","author":"R Sato","year":"2025","unstructured":"Sato R, Messina S, Hasegawa D, Santonocito C, Scimonello G, Sanfilippo G, et al. Mortality in Patients With Sepsis Treated With Esmolol or Landiolol: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis. Chest. 2025;167:121\u201338. https:\/\/doi.org\/10.1016\/j.chest.2024.08.020.","journal-title":"Chest"},{"key":"6109_CR126","doi-asserted-by":"publisher","first-page":"e1125","DOI":"10.1097\/ccm.0000000000006604","volume":"53","author":"C McChesney","year":"2025","unstructured":"McChesney C, Orozco N, Fiorini K, Wong MYS, Slessarev M, Prager R, et al. Impact of Short-Acting Beta-Blockers on the Outcomes of Patients With Septic Shock: A Systematic Review and Meta-Analysis. Crit Care Med. 2025;53:e1125\u201339. https:\/\/doi.org\/10.1097\/ccm.0000000000006604.","journal-title":"Crit Care Med"},{"key":"6109_CR127","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.chest.2024.09.007","volume":"167","author":"T Whitehouse","year":"2025","unstructured":"Whitehouse T, Singer M. Beta Blockers and Septic Shock: More Work to Do. Chest. 2025;167:9\u201310. https:\/\/doi.org\/10.1016\/j.chest.2024.09.007.","journal-title":"Chest"},{"key":"6109_CR128","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s40635-019-0274-x","volume":"7","author":"S Lambden","year":"2019","unstructured":"Lambden S. Bench to bedside review: therapeutic modulation of nitric oxide in sepsis\u2014an update. Intensive Care Med Exp. 2019;7:64. https:\/\/doi.org\/10.1186\/s40635-019-0274-x.","journal-title":"Intensive Care Med Exp"},{"key":"6109_CR129","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/01.ccm.0000105581.01815.c6","volume":"32","author":"A L\u00f3pez","year":"2004","unstructured":"L\u00f3pez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med. 2004;32:21\u201330. https:\/\/doi.org\/10.1097\/01.ccm.0000105581.01815.c6.","journal-title":"Crit Care Med"},{"key":"6109_CR130","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2174\/1570161111311020004","volume":"11","author":"A Kimmoun","year":"2013","unstructured":"Kimmoun A, Ducrocq N, Levy B. Mechanisms of vascular hyporesponsiveness in septic shock. Curr Vasc Pharmacol. 2013;11:139\u201349. https:\/\/doi.org\/10.2174\/1570161111311020004.","journal-title":"Curr Vasc Pharmacol"},{"key":"6109_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04839-w","volume":"28","author":"J Arias-Ortiz","year":"2024","unstructured":"Arias-Ortiz J, Vincent J-L. Administration of methylene blue in septic shock: pros and cons. Crit Care. 2024;28:46. https:\/\/doi.org\/10.1186\/s13054-024-04839-w.","journal-title":"Crit Care"},{"key":"6109_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04397-7","volume":"27","author":"M Ibarra-Estrada","year":"2023","unstructured":"Ibarra-Estrada M, Kattan E, Aguilera-Gonz\u00e1lez P, Sandoval-Plascencia L, Rico-Jauregui U, G\u00f3mez-Partida CA, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial. Crit Care. 2023;27:110. https:\/\/doi.org\/10.1186\/s13054-023-04397-7.","journal-title":"Crit Care"},{"key":"6109_CR133","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/nm.2053","volume":"15","author":"J Xu","year":"2009","unstructured":"Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15:1318\u201321. https:\/\/doi.org\/10.1038\/nm.2053.","journal-title":"Nat Med"},{"key":"6109_CR134","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1038\/s41467-020-20231-y","volume":"11","author":"CH O\u2019Meara","year":"2020","unstructured":"O\u2019Meara CH, Coupland LA, Kordbacheh F, Quah BJC, Chang C-W, Davis DAS, et al. Neutralizing the pathological effects of extracellular histones with small polyanions. Nat Commun. 2020;11:6408. https:\/\/doi.org\/10.1038\/s41467-020-20231-y.","journal-title":"Nat Commun"},{"key":"6109_CR135","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13613-017-0340-z","volume":"7","author":"J Helms","year":"2017","unstructured":"Helms J, Clere-Jehl R, Bianchini E, Le Borgne P, Burban M, Zobairi F, et al. Thrombomodulin favors leukocyte microvesicle fibrinolytic activity, reduces NETosis and prevents septic shock-induced coagulopathy in rats. Ann Intensive Care. 2017;7:118. https:\/\/doi.org\/10.1186\/s13613-017-0340-z.","journal-title":"Ann Intensive Care"},{"key":"6109_CR136","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s13054-023-04741-x","volume":"27","author":"B Garcia","year":"2023","unstructured":"Garcia B, Su F, Dewachter L, Wang Y, Li N, Remmelink M, et al. Neutralization of extracellular histones by sodium-\u03b2-O-methyl cellobioside sulfate in septic shock. Crit Care. 2023;27:458. https:\/\/doi.org\/10.1186\/s13054-023-04741-x.","journal-title":"Crit Care"},{"key":"6109_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.70015","volume":"12","author":"R Bellomo","year":"2024","unstructured":"Bellomo R, Patava J, Van Lancker R, Layios N, Peetermans M, Plummer M, et al. A dose-adjusted, open-label, pilot study of the safety, tolerability, and pharmacokinetics of STC3141 in critically ill patients with sepsis. Pharmacol Res Perspect. 2024;12:e70015. https:\/\/doi.org\/10.1002\/prp2.70015.","journal-title":"Pharmacol Res Perspect"},{"key":"6109_CR138","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00134-025-07834-z","volume":"51","author":"M Ostermann","year":"2025","unstructured":"Ostermann M, Ferrer R, Rimmel\u00e9 T. Hemoadsorption in septic shock \u2013 PRO. Intensive Care Med. 2025;51:945\u20137. https:\/\/doi.org\/10.1007\/s00134-025-07834-z.","journal-title":"Intensive Care Med"},{"key":"6109_CR139","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"DM Payen","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, et al. ABDOMIX Group Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41:975\u201384. https:\/\/doi.org\/10.1007\/s00134-015-3751-z.","journal-title":"Intensive Care Med"},{"key":"6109_CR140","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320:1455. https:\/\/doi.org\/10.1001\/jama.2018.14618.","journal-title":"JAMA"},{"key":"6109_CR141","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44:2205\u201312. https:\/\/doi.org\/10.1007\/s00134-018-5463-7.","journal-title":"Intensive Care Med"},{"key":"6109_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(26)00047-0","author":"JA Neyra","year":"2026","unstructured":"Neyra JA, Legrand M, Tidswell MA, Al-Khafaji A, Galphin C, Rains R, et al. Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial. Lancet Respir Med. 2026. https:\/\/doi.org\/10.1016\/s2213-2600(26)00047-0.","journal-title":"Lancet Respir Med"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-026-06109-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06109-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-026-06109-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:05:49Z","timestamp":1787011549000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13054-026-06109-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6109"],"URL":"https:\/\/doi.org\/10.1186\/s13054-026-06109-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B. G. has received honoraria for presentations and participation in meetings related to DPP3, angiotensin II, and vasopressin, outside the scope of this work. S. P. received payments for lectures from Viatris and AOP-Health. The other authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"427"}}